Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Metabolic evaluation of first-time and recurrent stone formers.

Goldfarb DS, Arowojolu O.

Urol Clin North Am. 2013 Feb;40(1):13-20. doi: 10.1016/j.ucl.2012.09.007. Epub 2012 Oct 27. Review.

2.

Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.

Prezioso D, Strazzullo P, Lotti T, Bianchi G, Borghi L, Caione P, Carini M, Caudarella R, Ferraro M, Gambaro G, Gelosa M, Guttilla A, Illiano E, Martino M, Meschi T, Messa P, Miano R, Napodano G, Nouvenne A, Rendina D, Rocco F, Rosa M, Sanseverino R, Salerno A, Spatafora S, Tasca A, Ticinesi A, Travaglini F, Trinchieri A, Vespasiani G, Zattoni F; CLU Working Group.

Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Review. Erratum in: Arch Ital Urol Androl. 2016 Mar;88(1):76. Ferraro, Manuel [added].

3.

Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.

Curhan GC, Willett WC, Speizer FE, Stampfer MJ.

Kidney Int. 2001 Jun;59(6):2290-8.

4.

Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.

Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.

J Urol. 2009 Mar;181(3):1140-4. doi: 10.1016/j.juro.2008.11.020. Epub 2009 Jan 18.

PMID:
19152919
5.

Kidney stones. Medical management and newer options for stone 'removal'.

Kanig SP, Conn RL.

Postgrad Med. 1985 Nov 1;78(6):38-44, 47-51.

PMID:
4059131
6.

[Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].

Hess B.

Ther Umsch. 2003 Feb;60(2):79-87. German.

PMID:
12649986
7.

Metabolic abnormalities associated with calyceal diverticular stones.

Auge BK, Maloney ME, Mathias BJ, Pietrow PK, Preminger GM.

BJU Int. 2006 May;97(5):1053-6.

8.

The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.

DeFoor WR, Jackson E, Minevich E, Caillat A, Reddy P, Sheldon C, Asplin J.

Urology. 2010 Jul;76(1):242-5. doi: 10.1016/j.urology.2009.09.084. Epub 2010 Jan 27.

PMID:
20110113
9.

[Functional evaluation in patients with kidney calculi].

Stojimirović B.

Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8. Review. Serbian.

PMID:
9863414
10.

Intestinal oxalate and calcium absorption in recurrent renal stone formers and healthy subjects.

Lindsjö M, Danielson BG, Fellström B, Ljunghall S.

Scand J Urol Nephrol. 1989;23(1):55-9.

PMID:
2922580
11.

Can obese stone formers follow dietary recommendations?

Torricelli FC, De S, Li I, Sarkissian C, Monga M.

J Endourol. 2014 Feb;28(2):248-51. doi: 10.1089/end.2013.0536. Epub 2013 Nov 4.

PMID:
24032438
12.

Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?

Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M.

Urol Int. 2003;70(4):273-7.

PMID:
12740490
13.

Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.

Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM.

J Urol. 2004 Jul;172(1):159-63.

PMID:
15201761
14.

Dietary style and acid load in an Italian population of calcium kidney stone formers.

Vezzoli G, Dogliotti E, Terranegra A, Arcidiacono T, Macrina L, Tavecchia M, Pivari F, Mingione A, Brasacchio C, Nouvenne A, Meschi T, Cusi D, Spotti D, Montanari E, Soldati L.

Nutr Metab Cardiovasc Dis. 2015 Jun;25(6):588-93. doi: 10.1016/j.numecd.2015.03.005. Epub 2015 Mar 20.

PMID:
25921845
15.

Evaluation of the recurrent stone former.

Chandhoke PS.

Urol Clin North Am. 2007 Aug;34(3):315-22. Review.

PMID:
17678982
16.

Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.

Eisner BH, Sheth S, Dretler SP, Herrick B, Pais VM Jr.

Urology. 2012 Oct;80(4):776-9. doi: 10.1016/j.urology.2012.06.034. Epub 2012 Aug 22.

PMID:
22921696
17.

Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.

Schwille PO, Scholz D, Schwille K, Leutschaft R, Goldberg I, Sigel A.

Nephron. 1982;31(3):194-202.

PMID:
7121665
18.

Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.

Gault MH, Chafe LL, Morgan JM, Parfrey PS, Harnett JD, Walsh EA, Prabhakaran VM, Dow D, Colpitts A.

Medicine (Baltimore). 1991 Nov;70(6):345-59.

PMID:
1956278
19.

A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria.

Okonkwo OW, Batwara R, Granja I, Asplin JR, Goldfarb DS.

PLoS One. 2013 Apr 8;8(4):e60380. doi: 10.1371/journal.pone.0060380. Print 2013.

20.

Effect of being overweight on urinary metabolic risk factors for kidney stone formation.

Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, Unwin R.

Nephrol Dial Transplant. 2015 Apr;30(4):607-13. doi: 10.1093/ndt/gfu350. Epub 2014 Oct 31.

PMID:
25362001

Supplemental Content

Support Center